Pharmacology

This editorial commentary discusses the expanding therapeutic landscape of GLP-1 receptor agonists, from diabetes management to cardiovascular risk reduction, obesity treatment, and emerging neurological applications.

This systematic review examines the epidemiological evidence linking metformin use to cancer risk reduction and explores the proposed biological mechanisms underlying its potential antineoplastic properties.